Improving patient outcomes through early cancer detection.
Our Core Technology
Our mission at Naveris is to deliver disruptive technology with the potential to transform cancer detection and improve patient outcomes.
Highly Sensitive Blood Tests
Early cancer diagnosis in the general asymptomatic population.
Transform Cancer Detection
Real-time monitoring of response in patients undergoing treatment.
Improve Patient Outcomes
Detection of cancer recurrence in patients in remission.
Recent Posts / View All Posts
“A saliva-based diagnostic test that can detect HPV-related head and neck cancer has the potential to catch the disease earlier and even serve as a standard screening method, which the…
For Release: June 2, 2021 Waltham, MA— A new clinically-validated saliva test has been shown to detect HPV-associated head and neck cancer with high accuracy, a first-of-its-kind study result. Researchers…
"NATICK, Mass.--(BUSINESS WIRE)--Naveris, a healthcare company dedicated to improving patient care through early detection of virus-related cancers, today announced the close of its expanded Series A financing, bringing the total…
Mar 24, 2020 | Molika Ashford NEW YORK – Investigators from the University of North Carolina at Chapel Hill have reached a new milestone for their virus-associated oropharyngeal cancer detection…